trump on glp 1 GLP-1 price reduction: President announces deal to reduce costs Trump Says He 'Probably Should'

At six months, ongoing program utilization and medication adherence significantly exceeded industry benchmarks, helping reduce future healthcare spend

Pancreatitis: Can I take it

A Doctor Weighs In on lemme "Ozempic" Controversy Following backlash for releasing OTC Ozempic, experts weigh in on its safety

Why This Model Appeals to Many Users AltRx simplifies what is usually a complex process: No in-person doctor visits No insurance dependency Faster access to treatment Lower starting cost compared to brand-name drugs At the same time, it still keeps a medical approval step, which helps position it as a prescription-based program rather than a supplement or shortcut